Search Within

Sujata Patil

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (12)
Groups
  1. Advanced Practice Providers (31)
  2. Biostatistics Service (31)
  3. Epidemiology and Biostatistics (31)
  4. Surgery (30)
  5. Survivorship Research (27)
  6. Nursing (25)

More Groups

People
  1. Darren Feldman (12)
  2. George Bosl (12)
  3. Jessica Goldberg (12)
  4. Kimberly Van Zee (12)
  5. Robert Motzer (12)
  6. Joel Sheinfeld (11)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2018 (1)
  4. 2016 (1)
  5. 2015 (3)
  6. 2014 (2)

More Years

Publications
  1. Journal of Clinical Oncology (15)
  2. Annals of Surgical Oncology (6)
  3. Cancer (2)
  4. Cancer Research (2)
  5. Annals of Surgery (1)
  6. Biology of Blood and Marrow Transplantation (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. Springer (8)
  3. American Association for Cancer Research (2)
  4. Elsevier Inc. (2)
  5. Wiley Blackwell (2)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Four cycles of etoposide plus cisplatin for patients with good-risk advanced germ cell tumors
    Journal Article

    Funt, S. A.; McHugh, D. J.; Tsai, S.; Knezevic, A.; O'Donnell, D.; Patil, S.; Silber, D.; Bromberg, M.; Carousso, M.; Reuter, V. E.; more...
    The Oncologist (2021)

    Fulltext@MSK | Save
  • Objective and subjective vulvovaginal symptoms in breast cancer patients
    Meeting Abstract

    Goldfarb, S. B.; Saban, S.; Arkema, A.; Patil, S.; Flynn, J.; Goldfrank, D. J.; Norton, L.; Carter, J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts)
    Meeting Abstract

    Funt, S.; McHugh, D. J.; Tsai, S.; O'Donnell, D.; Knezevic, A.; Patil, S.; Silber, D.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Paclitaxel, ifosfamide, and cisplatin efficacy for first-line treatment of patients with intermediate- or poor-risk germ cell tumors
    Journal Article

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Lim, K.; Patil, S.; Woo, K. M.; Carousso, M.; Hughes, A.; Sheinfeld, J.; Bains, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Lobular carcinoma in situ: A 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk
    Journal Article

    King, T. A.; Pilewskie, M.; Muhsen, S.; Patil, S.; Mautner, S. K.; Park, A.; Oskar, S.; Guerini Rocco, E.; Boafo, C.; Gooch, J. C.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I/II trial of paclitaxel with ifosfamide followed by high-dose paclitaxel, ifosfamide, and carboplatin (TI-TIC) with autologous stem cell reinfusion for salvage treatment of germ cell tumors
    Journal Article

    Feldman, D. R.; Glezerman, I.; Patil, S.; Van Alstine, L.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M.; Reich, L.; more...
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save
  • The extent of lobular carcinoma in situ (LCIS) at surgical excision predicts for the development of subsequent breast cancer
    Meeting Abstract

    Gooch, J. C.; Guerini Rocco, E.; Patil, S.; Koslow, S. B.; De Brot, M.; Park, A. Y.; Boafo, C. A.; Reis, J. S.; King, T. A.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Acute changes in endothelial function with cisplatin among germ cell tumor (GCT) patients (Pts)
    Meeting Abstract

    Feldman, D. R.; Jacobsen, E. P.; Woo, K.; Steingart, R.; Fleisher, M.; Patil, S.; Carousso, M.; Laguerre, S.; Morales, T. D.; Sheinfeld, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I/II study of paclitaxel plus ifosfamide followed by high-dose paclitaxel, ifosfamide, and carboplatin with autologous stem cell reinfusion for salvage treatment of germ cell tumors
    Meeting Abstract

    Feldman, D. R.; Glezerman, I.; Patil, S.; Van Alstine, L.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M.; Reich, L.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save